BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10398146)

  • 21. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of cytokeratin 20 in thyroid carcinomas and peripheral blood detected by reverse transcription polymerase chain reaction.
    Weber T; Lacroix J; Weitz J; Amnan K; Magener A; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
    Br J Cancer; 2000 Jan; 82(1):157-60. PubMed ID: 10638983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
    Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
    Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of cholecystokinin-B/gastrin receptors in medullary thyroid cancer.
    Amiri-Mosavi A; Ahlman H; Tisell LE; Wängberg B; Kölby L; Forssell-Aronsson E; Lundberg PA; Lindstedt G; Nilsson O
    Eur J Surg; 1999 Jul; 165(7):628-31. PubMed ID: 10452255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of duration of fixation on quantitative reverse transcription polymerase chain reaction analyses.
    Macabeo-Ong M; Ginzinger DG; Dekker N; McMillan A; Regezi JA; Wong DT; Jordan RC
    Mod Pathol; 2002 Sep; 15(9):979-87. PubMed ID: 12218216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gene expression profiles in thyroid carcinomas.
    Takano T; Hasegawa Y; Matsuzuka F; Miyauchi A; Yoshida H; Higashiyama T; Kuma K; Amino N
    Br J Cancer; 2000 Dec; 83(11):1495-502. PubMed ID: 11076659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of disseminated medullary thyroid carcinoma cells in cervical lymph nodes by cytokeratin 20 reverse transcription-polymerase chain reaction.
    Weber T; Amann K; Weckauf H; Lacroix J; Weitz J; Schönfuss T; Hölting T; Klar E; Herfarth C; von Knebel Doeberitz M
    World J Surg; 2002 Feb; 26(2):148-52. PubMed ID: 11865340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissue.
    Brönnegård M; Törring O; Böös J; Sylven C; Marcus C; Wallin G
    J Clin Endocrinol Metab; 1994 Aug; 79(2):384-9. PubMed ID: 8045952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.
    Elisei R; Pinchera A; Romei C; Gryczynska M; Pohl V; Maenhaut C; Fugazzola L; Pacini F
    J Clin Endocrinol Metab; 1994 Apr; 78(4):867-71. PubMed ID: 8157713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid-stimulating hormone receptor levels and binding affinity in the thyroid gland of growth-retarded mice.
    Kobayashi K; Sato M; Machida T; Kobayashi T
    Congenit Anom (Kyoto); 2005 Sep; 45(3):89-92. PubMed ID: 16131366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caveolin-1 and caveolin-2,together with three bone morphogenetic protein-related genes, may encode novel tumor suppressors down-regulated in sporadic follicular thyroid carcinogenesis.
    Aldred MA; Ginn-Pease ME; Morrison CD; Popkie AP; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang SM; Plass C; Eng C
    Cancer Res; 2003 Jun; 63(11):2864-71. PubMed ID: 12782592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of oncofetal fibronectin mRNA in thyroid anaplastic carcinoma.
    Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
    Jpn J Clin Oncol; 2007 Sep; 37(9):647-51. PubMed ID: 17704536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of the thyroid-stimulating hormone receptor in poorly-differentiated carcinoma of the thyroid.
    Matsumoto H; Sakamoto A; Fujiwara M; Yano Y; Shishido-Hara Y; Fujioka Y; Kamma H
    Oncol Rep; 2008 Jun; 19(6):1405-11. PubMed ID: 18497944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Xenotransplanted thyroid tumors heterogeneously express differentiation markers in nude rats.
    Hoang-Vu C; Scheumann GF; Dralle H; Schröder S; von zur Mühlen A; Brabant G
    Transplant Proc; 1993 Oct; 25(5):2799. PubMed ID: 8212238
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification of tumour-specific translocations in archival material.
    Williams GH; Williams ED
    J Pathol; 1995 Mar; 175(3):279-81. PubMed ID: 7538162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of thyroid-stimulating hormone receptor mRNA with real-time PCR for early diagnosis of papillary thyroid microcarcinoma.
    Qiu J; Zhang Y; Guo X; Zeng F; Zhao C; Qiu X; Wu X
    Neoplasma; 2010; 57(4):360-4. PubMed ID: 20429628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measurement of the expression of oncofetal fibronectin mRNA in thyroid carcinomas by competitive reverse transcription-polymerase chain reaction.
    Higashiyama T; Takano T; Matsuzuka F; Liu G; Miyauchi A; Yokozawa T; Morita S; Kuma K; Shiba E; Noguchi S; Amino N
    Thyroid; 1999 Mar; 9(3):235-40. PubMed ID: 10211598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of thyrotrophin receptor gene in thyroid carcinoma is associated with a good prognosis.
    Shi Y; Zou M; Farid NR
    Clin Endocrinol (Oxf); 1993 Sep; 39(3):269-74. PubMed ID: 8222289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor.
    Ruggeri RM; Villari D; Simone A; Scarfi R; Attard M; Orlandi F; Barresi G; Trimarchi F; Trovato M; Benvenga S
    J Endocrinol Invest; 2002 Dec; 25(11):959-66. PubMed ID: 12553555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.